Denali Therapeutics Inc.
Denali Therapeutics Inc. (DNLI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dnli · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Buy
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$40.00
Consensus
$30.80
+57.6% upside
Low
$23.00
Median: $31 · Last Close: $19.54
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$30.80
57.6% upside
High Target
$40
104.7%
Low Target
$23
17.7%
Current Price
$19.54
as of today
Based on analyst price targets, the DNLI stock price prediction for the next 12 months ranges from $23 to $40. The consensus DNLI price forecast of $30.80 implies 57.6% upside from the current price of $19.54.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $19.61 | ↑ 0.34% |
1-day model range: $19.49–$19.72. Peak: $19.72 (+0.34%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -28.6% |
| 2028 | $12 | -40.9% |
| 2029 | $10 | -47.0% |
| 2030 | $10 | -50.3% |
| 2031 | — | -52.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DNLI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-14 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-11 | BTIG | Maintains | Buy→Buy |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-22 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-04-07 | Baird | Maintains | Outperform→Outperform |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-26 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-03-26 | Stifel | Maintains | Buy→Buy |
| 2026-03-26 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Denali Therapeutics Inc. (DNLI) stock. Of the recent 86 rating actions, 2 were upgrades and 3 were downgrades. 18 analysts currently cover DNLI.
Analyst Recommendation Trends
DNLI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$48M
↓ 88.6% YoY
Revenue Next Year
$113M
↑ 135.6% YoY
EPS This Year
$-2.46
EPS Next Year
$-2.43
↓ 1.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast DNLI EPS of $-2.46 for the current fiscal year, based on estimates from 14 analysts. The DNLI revenue forecast is $48M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DNLI stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DNLI price target is $30.80 (+57.6% upside), with an analyst consensus of Buy.
The DNLI short-term stock prediction for tomorrow is $19.61 (+0.34%). The DNLI stock price prediction for 2027 estimates an average of $14. The DNLI stock prediction for 2030 projects a range of $9–$10.
Denali Therapeutics Inc. trades on NASDAQ under the ticker DNLI. The DNLI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
DNLI forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month DNLI price target is $30.80, with a high forecast of $40.00 and a low of $23.00. The median price target is shown in the chart above when available. This implies +57.6% potential upside from the current price of $19.54.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.